Sbir phase i, topic 331: optical spectroscopy capable biopsy needle tip to seek high tumor content areas
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201400058C
- Awardee
-
Ziva Corporation UEI KVVGDUKJ5DU9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,977
Award facts
- Opportunity
-
- PHS20141 Solicitation number
- PHS 2014-1 Amendment 3 Award Notice · Posted Aug 14, 2013
- Contract value 100% obligated
- $224,977.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 9 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $224,977 |
About this award
This is a $224,977.00 firm-fixed-price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Ziva Corporation, a small business, under the Small Business Innovation Research (SBIR) program. The contract is for Phase I of a project to develop an optical spectroscopy-capable biopsy needle tip that can identify high tumor content areas. The contract has a completion date of February 21, 2016 and was awarded on September 22, 2014. Ziva Corporation is a technology company that specializes in developing novel radio frequency (RF) and optical technologies for defense and commercial applications, and has a history of prime and subcontract work with various U.S. government agencies.
Quick answers
Who was awarded contract HHSN261201400058C?
HHSN261201400058C was awarded to Ziva Corporation by National Cancer Institute (National Institutes of Health) on September 22, 2014.
How much is contract HHSN261201400058C worth?
The government has obligated $224,977 on HHSN261201400058C.
Was contract HHSN261201400058C competed?
The extent of competition for HHSN261201400058C was full and open competition after exclusion of sources. The government received 9 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award